Ulipristal acetate 5mg (Esmya): further restrictions due to risk of serious liver injury

Although temporary suspension has been lifted, it should only be used for intermittent treatment of moderate to severe symptoms of uterine fibroids before menopause and when surgical procedures (including uterine fibroid embolisation) are not suitable or have failed.

SPS commentary:

Dear HCP letter


Medicines and Healthcare products Regulatory Agency